Global Peptide Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 117

Published Date: 10 Jan 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Peptide vaccines include one or more short or long amino acids sequences, as an antigen combined with a vaccine adjuvant. Thus they fall in the broad category of defined antigen vaccines, along with the vaccines using proteins, protein sub units, DNA and RNA. They remain the most immunogenic approaches based on the measures of T-cell responses. Peptide immunogenicity is influenced by the way in which peptides are presented to the immune system, underscoring the need for multifunctional delivery systems that couple antigen and adjuvant into a single construct.

According to our (Global Info Research) latest study, the global Peptide Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Peptide Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Peptide Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Peptide Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Peptide Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2018-2029
Global Peptide Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Peptide Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Peptide Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anergis, Antigen Express, Apitope Technology, Artificial Cell Technologies and Benovus Bio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Peptide Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Solution Phase Synthesis (SPS)
    Solid Phase Peptide Synthesis (SPPS)

Market segment by Application
    Prostate Cancer
    Breast Cancer
    Gastric Cancer
    Lung Cancer
    Pancreatic Cancer
    Others

Major players covered
    Anergis
    Antigen Express
    Apitope Technology
    Artificial Cell Technologies
    Benovus Bio
    Celgene Corporation
    Immatics biotechnologies
    Merck
    ImmunoCellular Therapeutics
    ISA Pharmaceuticals
    Lytix Biopharma
    Spotlight Innovation
    OncoTherapy Science
    Peptech
    Pharmasyntez
    Sumitomo Dainippon Pharma
    TapImmune
    Targovax

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Peptide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Peptide Vaccine, with price, sales, revenue and global market share of Peptide Vaccine from 2018 to 2023.
Chapter 3, the Peptide Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Peptide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Peptide Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Peptide Vaccine.
Chapter 14 and 15, to describe Peptide Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Peptide Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Peptide Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Solution Phase Synthesis (SPS)
        1.3.3 Solid Phase Peptide Synthesis (SPPS)
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Peptide Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Prostate Cancer
        1.4.3 Breast Cancer
        1.4.4 Gastric Cancer
        1.4.5 Lung Cancer
        1.4.6 Pancreatic Cancer
        1.4.7 Others
    1.5 Global Peptide Vaccine Market Size & Forecast
        1.5.1 Global Peptide Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Peptide Vaccine Sales Quantity (2018-2029)
        1.5.3 Global Peptide Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Anergis
        2.1.1 Anergis Details
        2.1.2 Anergis Major Business
        2.1.3 Anergis Peptide Vaccine Product and Services
        2.1.4 Anergis Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Anergis Recent Developments/Updates
    2.2 Antigen Express
        2.2.1 Antigen Express Details
        2.2.2 Antigen Express Major Business
        2.2.3 Antigen Express Peptide Vaccine Product and Services
        2.2.4 Antigen Express Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Antigen Express Recent Developments/Updates
    2.3 Apitope Technology
        2.3.1 Apitope Technology Details
        2.3.2 Apitope Technology Major Business
        2.3.3 Apitope Technology Peptide Vaccine Product and Services
        2.3.4 Apitope Technology Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Apitope Technology Recent Developments/Updates
    2.4 Artificial Cell Technologies
        2.4.1 Artificial Cell Technologies Details
        2.4.2 Artificial Cell Technologies Major Business
        2.4.3 Artificial Cell Technologies Peptide Vaccine Product and Services
        2.4.4 Artificial Cell Technologies Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Artificial Cell Technologies Recent Developments/Updates
    2.5 Benovus Bio
        2.5.1 Benovus Bio Details
        2.5.2 Benovus Bio Major Business
        2.5.3 Benovus Bio Peptide Vaccine Product and Services
        2.5.4 Benovus Bio Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Benovus Bio Recent Developments/Updates
    2.6 Celgene Corporation
        2.6.1 Celgene Corporation Details
        2.6.2 Celgene Corporation Major Business
        2.6.3 Celgene Corporation Peptide Vaccine Product and Services
        2.6.4 Celgene Corporation Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Celgene Corporation Recent Developments/Updates
    2.7 Immatics biotechnologies
        2.7.1 Immatics biotechnologies Details
        2.7.2 Immatics biotechnologies Major Business
        2.7.3 Immatics biotechnologies Peptide Vaccine Product and Services
        2.7.4 Immatics biotechnologies Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Immatics biotechnologies Recent Developments/Updates
    2.8 Merck
        2.8.1 Merck Details
        2.8.2 Merck Major Business
        2.8.3 Merck Peptide Vaccine Product and Services
        2.8.4 Merck Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Merck Recent Developments/Updates
    2.9 ImmunoCellular Therapeutics
        2.9.1 ImmunoCellular Therapeutics Details
        2.9.2 ImmunoCellular Therapeutics Major Business
        2.9.3 ImmunoCellular Therapeutics Peptide Vaccine Product and Services
        2.9.4 ImmunoCellular Therapeutics Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 ImmunoCellular Therapeutics Recent Developments/Updates
    2.10 ISA Pharmaceuticals
        2.10.1 ISA Pharmaceuticals Details
        2.10.2 ISA Pharmaceuticals Major Business
        2.10.3 ISA Pharmaceuticals Peptide Vaccine Product and Services
        2.10.4 ISA Pharmaceuticals Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 ISA Pharmaceuticals Recent Developments/Updates
    2.11 Lytix Biopharma
        2.11.1 Lytix Biopharma Details
        2.11.2 Lytix Biopharma Major Business
        2.11.3 Lytix Biopharma Peptide Vaccine Product and Services
        2.11.4 Lytix Biopharma Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Lytix Biopharma Recent Developments/Updates
    2.12 Spotlight Innovation
        2.12.1 Spotlight Innovation Details
        2.12.2 Spotlight Innovation Major Business
        2.12.3 Spotlight Innovation Peptide Vaccine Product and Services
        2.12.4 Spotlight Innovation Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Spotlight Innovation Recent Developments/Updates
    2.13 OncoTherapy Science
        2.13.1 OncoTherapy Science Details
        2.13.2 OncoTherapy Science Major Business
        2.13.3 OncoTherapy Science Peptide Vaccine Product and Services
        2.13.4 OncoTherapy Science Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 OncoTherapy Science Recent Developments/Updates
    2.14 Peptech
        2.14.1 Peptech Details
        2.14.2 Peptech Major Business
        2.14.3 Peptech Peptide Vaccine Product and Services
        2.14.4 Peptech Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Peptech Recent Developments/Updates
    2.15 Pharmasyntez
        2.15.1 Pharmasyntez Details
        2.15.2 Pharmasyntez Major Business
        2.15.3 Pharmasyntez Peptide Vaccine Product and Services
        2.15.4 Pharmasyntez Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Pharmasyntez Recent Developments/Updates
    2.16 Sumitomo Dainippon Pharma
        2.16.1 Sumitomo Dainippon Pharma Details
        2.16.2 Sumitomo Dainippon Pharma Major Business
        2.16.3 Sumitomo Dainippon Pharma Peptide Vaccine Product and Services
        2.16.4 Sumitomo Dainippon Pharma Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Sumitomo Dainippon Pharma Recent Developments/Updates
    2.17 TapImmune
        2.17.1 TapImmune Details
        2.17.2 TapImmune Major Business
        2.17.3 TapImmune Peptide Vaccine Product and Services
        2.17.4 TapImmune Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 TapImmune Recent Developments/Updates
    2.18 Targovax
        2.18.1 Targovax Details
        2.18.2 Targovax Major Business
        2.18.3 Targovax Peptide Vaccine Product and Services
        2.18.4 Targovax Peptide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.18.5 Targovax Recent Developments/Updates

3 Competitive Environment: Peptide Vaccine by Manufacturer
    3.1 Global Peptide Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Peptide Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global Peptide Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Peptide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Peptide Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 Peptide Vaccine Manufacturer Market Share in 2022
    3.5 Peptide Vaccine Market: Overall Company Footprint Analysis
        3.5.1 Peptide Vaccine Market: Region Footprint
        3.5.2 Peptide Vaccine Market: Company Product Type Footprint
        3.5.3 Peptide Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Peptide Vaccine Market Size by Region
        4.1.1 Global Peptide Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global Peptide Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global Peptide Vaccine Average Price by Region (2018-2029)
    4.2 North America Peptide Vaccine Consumption Value (2018-2029)
    4.3 Europe Peptide Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific Peptide Vaccine Consumption Value (2018-2029)
    4.5 South America Peptide Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa Peptide Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Peptide Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global Peptide Vaccine Consumption Value by Type (2018-2029)
    5.3 Global Peptide Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Peptide Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global Peptide Vaccine Consumption Value by Application (2018-2029)
    6.3 Global Peptide Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America Peptide Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America Peptide Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America Peptide Vaccine Market Size by Country
        7.3.1 North America Peptide Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America Peptide Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Peptide Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe Peptide Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe Peptide Vaccine Market Size by Country
        8.3.1 Europe Peptide Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe Peptide Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Peptide Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Peptide Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Peptide Vaccine Market Size by Region
        9.3.1 Asia-Pacific Peptide Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Peptide Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Peptide Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America Peptide Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America Peptide Vaccine Market Size by Country
        10.3.1 South America Peptide Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America Peptide Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Peptide Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Peptide Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Peptide Vaccine Market Size by Country
        11.3.1 Middle East & Africa Peptide Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Peptide Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Peptide Vaccine Market Drivers
    12.2 Peptide Vaccine Market Restraints
    12.3 Peptide Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Peptide Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Peptide Vaccine
    13.3 Peptide Vaccine Production Process
    13.4 Peptide Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Peptide Vaccine Typical Distributors
    14.3 Peptide Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Peptide Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Peptide Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Anergis Basic Information, Manufacturing Base and Competitors
    Table 4. Anergis Major Business
    Table 5. Anergis Peptide Vaccine Product and Services
    Table 6. Anergis Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Anergis Recent Developments/Updates
    Table 8. Antigen Express Basic Information, Manufacturing Base and Competitors
    Table 9. Antigen Express Major Business
    Table 10. Antigen Express Peptide Vaccine Product and Services
    Table 11. Antigen Express Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Antigen Express Recent Developments/Updates
    Table 13. Apitope Technology Basic Information, Manufacturing Base and Competitors
    Table 14. Apitope Technology Major Business
    Table 15. Apitope Technology Peptide Vaccine Product and Services
    Table 16. Apitope Technology Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Apitope Technology Recent Developments/Updates
    Table 18. Artificial Cell Technologies Basic Information, Manufacturing Base and Competitors
    Table 19. Artificial Cell Technologies Major Business
    Table 20. Artificial Cell Technologies Peptide Vaccine Product and Services
    Table 21. Artificial Cell Technologies Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Artificial Cell Technologies Recent Developments/Updates
    Table 23. Benovus Bio Basic Information, Manufacturing Base and Competitors
    Table 24. Benovus Bio Major Business
    Table 25. Benovus Bio Peptide Vaccine Product and Services
    Table 26. Benovus Bio Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Benovus Bio Recent Developments/Updates
    Table 28. Celgene Corporation Basic Information, Manufacturing Base and Competitors
    Table 29. Celgene Corporation Major Business
    Table 30. Celgene Corporation Peptide Vaccine Product and Services
    Table 31. Celgene Corporation Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Celgene Corporation Recent Developments/Updates
    Table 33. Immatics biotechnologies Basic Information, Manufacturing Base and Competitors
    Table 34. Immatics biotechnologies Major Business
    Table 35. Immatics biotechnologies Peptide Vaccine Product and Services
    Table 36. Immatics biotechnologies Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Immatics biotechnologies Recent Developments/Updates
    Table 38. Merck Basic Information, Manufacturing Base and Competitors
    Table 39. Merck Major Business
    Table 40. Merck Peptide Vaccine Product and Services
    Table 41. Merck Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Merck Recent Developments/Updates
    Table 43. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 44. ImmunoCellular Therapeutics Major Business
    Table 45. ImmunoCellular Therapeutics Peptide Vaccine Product and Services
    Table 46. ImmunoCellular Therapeutics Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. ImmunoCellular Therapeutics Recent Developments/Updates
    Table 48. ISA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 49. ISA Pharmaceuticals Major Business
    Table 50. ISA Pharmaceuticals Peptide Vaccine Product and Services
    Table 51. ISA Pharmaceuticals Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. ISA Pharmaceuticals Recent Developments/Updates
    Table 53. Lytix Biopharma Basic Information, Manufacturing Base and Competitors
    Table 54. Lytix Biopharma Major Business
    Table 55. Lytix Biopharma Peptide Vaccine Product and Services
    Table 56. Lytix Biopharma Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Lytix Biopharma Recent Developments/Updates
    Table 58. Spotlight Innovation Basic Information, Manufacturing Base and Competitors
    Table 59. Spotlight Innovation Major Business
    Table 60. Spotlight Innovation Peptide Vaccine Product and Services
    Table 61. Spotlight Innovation Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Spotlight Innovation Recent Developments/Updates
    Table 63. OncoTherapy Science Basic Information, Manufacturing Base and Competitors
    Table 64. OncoTherapy Science Major Business
    Table 65. OncoTherapy Science Peptide Vaccine Product and Services
    Table 66. OncoTherapy Science Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. OncoTherapy Science Recent Developments/Updates
    Table 68. Peptech Basic Information, Manufacturing Base and Competitors
    Table 69. Peptech Major Business
    Table 70. Peptech Peptide Vaccine Product and Services
    Table 71. Peptech Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Peptech Recent Developments/Updates
    Table 73. Pharmasyntez Basic Information, Manufacturing Base and Competitors
    Table 74. Pharmasyntez Major Business
    Table 75. Pharmasyntez Peptide Vaccine Product and Services
    Table 76. Pharmasyntez Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Pharmasyntez Recent Developments/Updates
    Table 78. Sumitomo Dainippon Pharma Basic Information, Manufacturing Base and Competitors
    Table 79. Sumitomo Dainippon Pharma Major Business
    Table 80. Sumitomo Dainippon Pharma Peptide Vaccine Product and Services
    Table 81. Sumitomo Dainippon Pharma Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Sumitomo Dainippon Pharma Recent Developments/Updates
    Table 83. TapImmune Basic Information, Manufacturing Base and Competitors
    Table 84. TapImmune Major Business
    Table 85. TapImmune Peptide Vaccine Product and Services
    Table 86. TapImmune Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 87. TapImmune Recent Developments/Updates
    Table 88. Targovax Basic Information, Manufacturing Base and Competitors
    Table 89. Targovax Major Business
    Table 90. Targovax Peptide Vaccine Product and Services
    Table 91. Targovax Peptide Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 92. Targovax Recent Developments/Updates
    Table 93. Global Peptide Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Dose)
    Table 94. Global Peptide Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 95. Global Peptide Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
    Table 96. Market Position of Manufacturers in Peptide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 97. Head Office and Peptide Vaccine Production Site of Key Manufacturer
    Table 98. Peptide Vaccine Market: Company Product Type Footprint
    Table 99. Peptide Vaccine Market: Company Product Application Footprint
    Table 100. Peptide Vaccine New Market Entrants and Barriers to Market Entry
    Table 101. Peptide Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 102. Global Peptide Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
    Table 103. Global Peptide Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
    Table 104. Global Peptide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 105. Global Peptide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 106. Global Peptide Vaccine Average Price by Region (2018-2023) & (US$/Dose)
    Table 107. Global Peptide Vaccine Average Price by Region (2024-2029) & (US$/Dose)
    Table 108. Global Peptide Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 109. Global Peptide Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 110. Global Peptide Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 111. Global Peptide Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 112. Global Peptide Vaccine Average Price by Type (2018-2023) & (US$/Dose)
    Table 113. Global Peptide Vaccine Average Price by Type (2024-2029) & (US$/Dose)
    Table 114. Global Peptide Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 115. Global Peptide Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 116. Global Peptide Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 117. Global Peptide Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 118. Global Peptide Vaccine Average Price by Application (2018-2023) & (US$/Dose)
    Table 119. Global Peptide Vaccine Average Price by Application (2024-2029) & (US$/Dose)
    Table 120. North America Peptide Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 121. North America Peptide Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 122. North America Peptide Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 123. North America Peptide Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 124. North America Peptide Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
    Table 125. North America Peptide Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
    Table 126. North America Peptide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 127. North America Peptide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 128. Europe Peptide Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 129. Europe Peptide Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 130. Europe Peptide Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 131. Europe Peptide Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 132. Europe Peptide Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
    Table 133. Europe Peptide Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
    Table 134. Europe Peptide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 135. Europe Peptide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 136. Asia-Pacific Peptide Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 137. Asia-Pacific Peptide Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 138. Asia-Pacific Peptide Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 139. Asia-Pacific Peptide Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 140. Asia-Pacific Peptide Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
    Table 141. Asia-Pacific Peptide Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
    Table 142. Asia-Pacific Peptide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 143. Asia-Pacific Peptide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 144. South America Peptide Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 145. South America Peptide Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 146. South America Peptide Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 147. South America Peptide Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 148. South America Peptide Vaccine Sales Quantity by Country (2018-2023) & (K Dose)
    Table 149. South America Peptide Vaccine Sales Quantity by Country (2024-2029) & (K Dose)
    Table 150. South America Peptide Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 151. South America Peptide Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 152. Middle East & Africa Peptide Vaccine Sales Quantity by Type (2018-2023) & (K Dose)
    Table 153. Middle East & Africa Peptide Vaccine Sales Quantity by Type (2024-2029) & (K Dose)
    Table 154. Middle East & Africa Peptide Vaccine Sales Quantity by Application (2018-2023) & (K Dose)
    Table 155. Middle East & Africa Peptide Vaccine Sales Quantity by Application (2024-2029) & (K Dose)
    Table 156. Middle East & Africa Peptide Vaccine Sales Quantity by Region (2018-2023) & (K Dose)
    Table 157. Middle East & Africa Peptide Vaccine Sales Quantity by Region (2024-2029) & (K Dose)
    Table 158. Middle East & Africa Peptide Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 159. Middle East & Africa Peptide Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 160. Peptide Vaccine Raw Material
    Table 161. Key Manufacturers of Peptide Vaccine Raw Materials
    Table 162. Peptide Vaccine Typical Distributors
    Table 163. Peptide Vaccine Typical Customers
List of Figures
    Figure 1. Peptide Vaccine Picture
    Figure 2. Global Peptide Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Peptide Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Solution Phase Synthesis (SPS) Examples
    Figure 5. Solid Phase Peptide Synthesis (SPPS) Examples
    Figure 6. Global Peptide Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Peptide Vaccine Consumption Value Market Share by Application in 2022
    Figure 8. Prostate Cancer Examples
    Figure 9. Breast Cancer Examples
    Figure 10. Gastric Cancer Examples
    Figure 11. Lung Cancer Examples
    Figure 12. Pancreatic Cancer Examples
    Figure 13. Others Examples
    Figure 14. Global Peptide Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 15. Global Peptide Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 16. Global Peptide Vaccine Sales Quantity (2018-2029) & (K Dose)
    Figure 17. Global Peptide Vaccine Average Price (2018-2029) & (US$/Dose)
    Figure 18. Global Peptide Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 19. Global Peptide Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 20. Producer Shipments of Peptide Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 21. Top 3 Peptide Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 22. Top 6 Peptide Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 23. Global Peptide Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 24. Global Peptide Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 25. North America Peptide Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Europe Peptide Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Asia-Pacific Peptide Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 28. South America Peptide Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 29. Middle East & Africa Peptide Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 30. Global Peptide Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 31. Global Peptide Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 32. Global Peptide Vaccine Average Price by Type (2018-2029) & (US$/Dose)
    Figure 33. Global Peptide Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 34. Global Peptide Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 35. Global Peptide Vaccine Average Price by Application (2018-2029) & (US$/Dose)
    Figure 36. North America Peptide Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 37. North America Peptide Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 38. North America Peptide Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 39. North America Peptide Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 40. United States Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Canada Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 42. Mexico Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 43. Europe Peptide Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 44. Europe Peptide Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 45. Europe Peptide Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 46. Europe Peptide Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 47. Germany Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. France Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. United Kingdom Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Russia Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 51. Italy Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 52. Asia-Pacific Peptide Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 53. Asia-Pacific Peptide Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 54. Asia-Pacific Peptide Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 55. Asia-Pacific Peptide Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 56. China Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Japan Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Korea Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. India Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. Southeast Asia Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 61. Australia Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 62. South America Peptide Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 63. South America Peptide Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 64. South America Peptide Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 65. South America Peptide Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 66. Brazil Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 67. Argentina Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 68. Middle East & Africa Peptide Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 69. Middle East & Africa Peptide Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 70. Middle East & Africa Peptide Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 71. Middle East & Africa Peptide Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 72. Turkey Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Egypt Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Saudi Arabia Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 75. South Africa Peptide Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 76. Peptide Vaccine Market Drivers
    Figure 77. Peptide Vaccine Market Restraints
    Figure 78. Peptide Vaccine Market Trends
    Figure 79. Porters Five Forces Analysis
    Figure 80. Manufacturing Cost Structure Analysis of Peptide Vaccine in 2022
    Figure 81. Manufacturing Process Analysis of Peptide Vaccine
    Figure 82. Peptide Vaccine Industrial Chain
    Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 84. Direct Channel Pros & Cons
    Figure 85. Indirect Channel Pros & Cons
    Figure 86. Methodology
    Figure 87. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Anergis
Antigen Express
Apitope Technology
Artificial Cell Technologies
Benovus Bio
Celgene Corporation
Immatics biotechnologies
Merck
ImmunoCellular Therapeutics
ISA Pharmaceuticals
Lytix Biopharma
Spotlight Innovation
OncoTherapy Science
Peptech
Pharmasyntez
Sumitomo Dainippon Pharma
TapImmune
Targovax

Related Reports

Global Peptide Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Peptide Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 01 Apr 2021

date Pharma & Healthcare

The Peptide Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Peptide Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Peptide Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 14 Jan 2022

date Pharma & Healthcare

Global Peptide Vaccine Supply, Demand and Key Producers, 2023-2029

Global Peptide Vaccine Supply, Demand and Key Producers, 2023-2029

date 23 Jan 2023

date Pharma & Healthcare

The global Peptide Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Peptide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Peptide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 04 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Peptide Vaccine market size was valued at USD 3789.6 million in 2023 and is forecast to a readjusted size of USD 5025.6 million by 2030 with a CAGR of 4.1% during review period.

Global Peptide Vaccine Supply, Demand and Key Producers, 2024-2030

Global Peptide Vaccine Supply, Demand and Key Producers, 2024-2030

date 29 Feb 2024

date Pharma & Healthcare

The global Peptide Vaccine market size is expected to reach $ 5025.6 million by 2030, rising at a market growth of 4.1% CAGR during the forecast period (2024-2030).

Product Tags

peptide vaccine

synthetic peptide vaccine

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>